J & amp;J Acquisition Could Give Stryker a Run for Its Money in Robotics

Johnson & Johnson is taking a deeper dive into the surgical robotics market through its latest acquisition. The New Brunswick, NJ-based company, through its French affiliate Apsis, will pick up Orthotaxy, a privately held developer of software-enabled surgical technologies, including a differentiated robotic-assisted surgery solution, for an undisclosed sum. J&J said the technology is currently in early-stage development for total and partial knee replacement, and the company plans to broaden its application for a range of orthopedic surgery procedures. Network with your colleagues in medtech at ADM Cleveland, March 7–8, 2018.   "Our goal is to bring to market a robotic-assisted surgery technology that is an integral part of a comprehensive orthopedics platform, delivering value to patients, physicians and healthcare providers across the episode of care," Ciro Rӧmer, Company Group Chairman of DePuy Synthes, the orthopedics business of J&J, said in a release. "The team at Orthotaxy has significant expertise and passion in developing this platform, and we aspire to bring to market a differentiated technology that helps improve clinical outcomes and increases patient satisfaction." The acquisition could help J&J compete more effectively against Stryker’s Mako orthopedic surgical solution. The Kalamazoo, MI-based company acquired Mako back in September 2013. Stryker caused a bit of controversy in the space when it made the market wait more than a year fo...
Source: MDDI - Category: Medical Devices Authors: Tags: Medical Device Business Source Type: news